OTUB1 and familial pancreatic carcinoma: The primary aim of this study was to investigate whether OTUB1 or NDUFS2 or both of them can be used as new prognostic biomarkers and/or therapeutic targets for pancreatic cancer and shed new lights into exploring therapeutic methods for pancreatic cancer.